Results 191 to 200 of about 86,874 (288)

Primary Endometrium Primitive Neuroectodermal Tumor with Diagnostic and Treatment Challenges: A Case Report. [PDF]

Int J Womens Health
Zhao H, Yang L, Shi Y, Yang L, Jiang W.
europepmc   +1 more source

The Functional Role and Molecular Characterization of the Therapeutic Target CLDN6 in Germ Cell Tumors

Andrology, EarlyView.
ABSTRACT Background The tight junction protein CLDN6 has been identified as a cancer‐associated cell surface marker that is rarely expressed in healthy tissues. In testicular germ cell tumors (GCT), CLDN6 is particularly detectable in seminomas, embryonal carcinomas, and choriocarcinomas.
Jule Zwick, Margaretha A. Skowron, Gereon Poschmann, Patrick Petzsch, Ann Kathrin Bergmann, Kai Stühler, Jochen Hecht, Daniel Nettersheim   +7 more
wiley   +1 more source

Hypercalcemia in poorly differentiated endometrial cancer: a report of two cases. [PDF]

Gynecol Oncol Rep
Zatsepina A, Cheliadinova U, Tiwari K, Li H, Singh V, Shaji RM, Resta C, Xu Y.   +7 more
europepmc   +1 more source

Cadaveric addendum to the consensus on ultrasound‐based lymph‐node staging in gynecological cancer

Ultrasound in Obstetrics &Gynecology, EarlyView.
D. Fischerova, E. Farsi, E. Facchetti, E. Panizzolo, G. Gambino, H. Reina, F. Sousa, M. R. Kadajari, N. Tiszlavicz, G. Garganese, O. Nanka, Collaborators, E. Gatti, C. Culcasi   +13 more
wiley   +1 more source

Menopausal hormone therapy after ovarian cancer: A 10‐year survival analysis in premenopausal women

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Among premenopausal women surgically treated for ovarian cancer, no difference in 10‐year overall survival was observed between postoperative MHT users and non‐users. Young ovarian cancer survivors should be recommended MHT after surgically induced menopause.
Åsa Ehlin von Kartaschew, Pernilla Dahm‐Kähler, Kenny Rodriguez Wallberg, Erik Holmberg, Angelique Flöter‐Rådestad   +4 more
wiley   +1 more source

Gynecologic tumors in Thai women with breast cancer: a cross-sectional surveillance and ten-year cohort study. [PDF]

Gland Surg
Jirakittidul P, Rattanachaiyanont M, Indhavivadhana S, Dangrat C, Vichinsartvichai P, Lohsiriwat V.   +5 more
europepmc   +1 more source

Seromucinous borderline ovarian tumors: Clinical and ultrasound characteristics and association with endometriosis

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Seromucinous borderline ovarian tumors frequently appear as unilateral, left‐sided cysts with ground‐glass echogenicity and moderately vascularized solid components. Their strong association with ipsilateral endometriosis provides crucial sonographic and clinical clues for an accurate preoperative diagnosis.
Simona Del Forno, Marisol Doglioli, Chiara Landolfo, Giovanna Palomba, Claudia Vicenzi, Matilde Antonelli, Lucia De Meis, Francesca Govoni, Roberto Paradisi, Diego Raimondo, Renato Seracchioli   +10 more
wiley   +1 more source

PD-1/PD-L1 inhibitors plus chemotherapy as first-line therapy for advanced or metastatic endometrial cancer: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Immunol
Huang Z, Li W, Li M, Huang Y, Lu Y, Hu J.   +5 more
europepmc   +1 more source

Magnetic resonance‐guided high‐intensity focused ultrasound (MR‐HIFU) therapy of uterine fibroids effectively reduces both bleeding and bulk symptoms—A prospective single‐center 12‐month follow‐up study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Magnetic resonance‐guided high‐intensity focused ultrasound (MR‐HIFU) resulted in significant symptom reduction and improved quality of life in patients with symptomatic uterine fibroids and either bleeding or bulk symptoms. When successful, MR‐HIFU provides effective and rapid symptom relief for both symptom types.
Saara Otonkoski, Antti Viitala, Gaber Komar, Teija Sainio, Anna Yanovskiy, Ina Lehtonen, Roberto Blanco Sequeiros, Antti Perheentupa, Kirsi Joronen   +8 more
wiley   +1 more source

Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert, Louise N. Nolan, Katja M. Schmalenberger   +2 more
wiley   +1 more source